Derer, S., Berger, S., Schlaeth, M., Schneider-Merck, T., Klausz, K., Lohse, S., . . . Valerius, T. (2012). Oncogenic KRAS Impairs EGFR Antibodies' Efficiency by C/EBPβ-Dependent Suppression of EGFR Expression. Neoplasia Press Inc.
Chicago Style CitationDerer, Stefanie, et al. Oncogenic KRAS Impairs EGFR Antibodies' Efficiency By C/EBPβ-Dependent Suppression of EGFR Expression. Neoplasia Press Inc, 2012.
Cita MLADerer, Stefanie, et al. Oncogenic KRAS Impairs EGFR Antibodies' Efficiency By C/EBPβ-Dependent Suppression of EGFR Expression. Neoplasia Press Inc, 2012.
Atenció: Aquestes cites poden no estar 100% correctes.